Literature DB >> 28718892

Methoxetamine affects brain processing involved in emotional response in rats.

M T Zanda1, P Fadda1, S Antinori1, M Di Chio2, W Fratta1, C Chiamulera2, L Fattore3.   

Abstract

BACKGROUND AND
PURPOSE: Methoxetamine (MXE) is a novel psychoactive substance that is emerging on the Internet and induces dissociative effects and acute toxicity. Its pharmacological effects have not yet been adequately investigated. EXPERIMENTAL APPROACH: We examined a range of behavioural effects induced by acute administration of MXE (0.5-5 mg·kg-1 ; i.p.) in rats and whether it causes rapid neuroadaptive molecular changes. KEY
RESULTS: MXE (0.5-5 mg·kg-1 ) affected motor activity in a dose- and time-dependent manner, inducing hypermotility and hypomotility at low and high doses respectively. At low and intermediate doses (0.5 and 1 mg·kg-1 ), MXE induced anxious and/or obsessive-compulsive traits (marble burying test), did not significantly increase sociability (social interaction test) or induce spatial anxiety (elevated plus maze test). At a high dose (5 mg·kg-1 ), MXE induced transient analgesia (tail-flick and hot-plate test), decreased social interaction time (social interaction test) and reduced immobility time while increasing swimming activity (forced swim test), suggesting an antidepressant effect. Acute MXE administration did not affect self-grooming behaviour at any dose tested. Immunohistochemical analysis showed that behaviourally active doses of MXE (1 and 5 mg·kg-1 ) increased phosphorylation of ribosomal protein S6 in the medial prefrontal cortex and hippocampus. CONCLUSIONS AND IMPLICATIONS: MXE differentially affected motor activity, behaviour and emotional states in rats, depending on the dose tested. As reported for ketamine, phosphorylation of the ribosomal protein S6 was increased in MXE-treated animals, thus providing a 'molecular snapshot' of rapid neuroadaptive molecular changes induced by behaviourally active doses of MXE.
© 2017 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28718892      PMCID: PMC5595753          DOI: 10.1111/bph.13952

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  89 in total

Review 1.  From "Special K" to "Special M": the evolution of the recreational use of ketamine and methoxetamine.

Authors:  Ornella Corazza; Sulaf Assi; Fabrizio Schifano
Journal:  CNS Neurosci Ther       Date:  2013-02-20       Impact factor: 5.243

2.  Cannabidiol reverses the mCPP-induced increase in marble-burying behavior.

Authors:  Mirella Nardo; Plinio C Casarotto; Felipe V Gomes; Francisco S Guimarães
Journal:  Fundam Clin Pharmacol       Date:  2013-10-25       Impact factor: 2.748

3.  Dose dependent effects of serotonergic agents on anxiety.

Authors:  M Kolcsar; Z Gáll; M T Dogaru
Journal:  Acta Physiol Hung       Date:  2014-12

4.  Methoxetamine, a ketamine derivative, produced conditioned place preference and was self-administered by rats: Evidence of its abuse potential.

Authors:  Chrislean Jun Botanas; June Bryan de la Peña; Irene Joy Dela Peña; Reinholdgher Tampus; Robin Yoon; Hee Jin Kim; Yong Sup Lee; Choon Gon Jang; Jae Hoon Cheong
Journal:  Pharmacol Biochem Behav       Date:  2015-03-17       Impact factor: 3.533

5.  Fatal intoxication with methoxetamine.

Authors:  Piotr Adamowicz; Dariusz Zuba
Journal:  J Forensic Sci       Date:  2014-11-20       Impact factor: 1.832

Review 6.  Animal models of obsessive-compulsive disorder: exploring pharmacology and neural substrates.

Authors:  Noa Albelda; Daphna Joel
Journal:  Neurosci Biobehav Rev       Date:  2011-04-15       Impact factor: 8.989

7.  A polydrug intoxication involving methoxetamine in a drugs and driving case.

Authors:  Albert A Elian; Jeffery Hackett
Journal:  J Forensic Sci       Date:  2014-02-15       Impact factor: 1.832

8.  Neurotoxicity screening of (illicit) drugs using novel methods for analysis of microelectrode array (MEA) recordings.

Authors:  L Hondebrink; A H A Verboven; W S Drega; S Schmeink; M W G D M de Groot; R G D M van Kleef; F M J Wijnolts; A de Groot; J Meulenbelt; R H S Westerink
Journal:  Neurotoxicology       Date:  2016-05-02       Impact factor: 4.294

9.  Memory impairment and reduced exploratory behavior in mice after administration of systemic morphine.

Authors:  Junichi Kitanaka; Nobue Kitanaka; F Scott Hall; Mei Fujii; Akiko Goto; Yusuke Kanda; Akira Koizumi; Hirotoshi Kuroiwa; Satoko Mibayashi; Yumi Muranishi; Soichiro Otaki; Minako Sumikawa; Koh-Ichi Tanaka; Nobuyoshi Nishiyama; George R Uhl; Motohiko Takemura
Journal:  J Exp Neurosci       Date:  2015-05-11

Review 10.  Ribosomal Protein S6 Phosphorylation in the Nervous System: From Regulation to Function.

Authors:  Anne Biever; Emmanuel Valjent; Emma Puighermanal
Journal:  Front Mol Neurosci       Date:  2015-12-16       Impact factor: 5.639

View more
  3 in total

1.  Methoxetamine affects brain processing involved in emotional response in rats.

Authors:  M T Zanda; P Fadda; S Antinori; M Di Chio; W Fratta; C Chiamulera; L Fattore
Journal:  Br J Pharmacol       Date:  2017-08-19       Impact factor: 8.739

Review 2.  New psychoactive substances: a review and updates.

Authors:  Abu Shafi; Alex J Berry; Harry Sumnall; David M Wood; Derek K Tracy
Journal:  Ther Adv Psychopharmacol       Date:  2020-12-17

Review 3.  Neuronal and peripheral damages induced by synthetic psychoactive substances: an update of recent findings from human and animal studies.

Authors:  Giulia Costa; Maria Antonietta De Luca; Gessica Piras; Jacopo Marongiu; Liana Fattore; Nicola Simola
Journal:  Neural Regen Res       Date:  2020-05       Impact factor: 5.135

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.